Combinations of Pharmacologic Smoking Cessation Treatments
Information source: Department of Veterans Affairs
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Smoking
Intervention: Bupropion (Drug); Mecamylamine (Drug); Nicotine Patch (Drug)
Phase: Phase 1
Status: Completed
Sponsored by: Department of Veterans Affairs Official(s) and/or principal investigator(s):
Neil Hartman, M.D.
Summary
The purpose of this study is to test the effectiveness of a combination of the drugs
bupropion and mecamylamine along with a nicotine patch as a therapy for smoking cessation.
Clinical Details
Official title: Combinations of Pharmacologic Smoking Cessation Treatments
Study design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Eligibility
Minimum age: 20 Years.
Maximum age: 40 Years.
Gender(s): Both.
Criteria:
Subjects must be a smoker between 20 and 40 years old, have smoked at least 20 cigarettes
per day for at least 2 years, wish to stop smoking and be in good general health
Locations and Contacts
VA Greater Los Angeles Healthcare System, Los Angeles, California 90073, United States
Additional Information
Starting date: November 1998
Ending date: June 2001
Last updated: May 7, 2007
|
